![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
64
PharmaCompass offers a list of Daclatasvir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Daclatasvir manufacturer or Daclatasvir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Daclatasvir manufacturer or Daclatasvir supplier.
PharmaCompass also assists you with knowing the Daclatasvir API Price utilized in the formulation of products. Daclatasvir API Price is not always fixed or binding as the Daclatasvir Price is obtained through a variety of data sources. The Daclatasvir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Daclatasvir Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Daclatasvir Dihydrochloride, including repackagers and relabelers. The FDA regulates Daclatasvir Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Daclatasvir Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Daclatasvir Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Daclatasvir Dihydrochloride supplier is an individual or a company that provides Daclatasvir Dihydrochloride active pharmaceutical ingredient (API) or Daclatasvir Dihydrochloride finished formulations upon request. The Daclatasvir Dihydrochloride suppliers may include Daclatasvir Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Daclatasvir Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Daclatasvir Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Daclatasvir Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Daclatasvir Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Daclatasvir Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Daclatasvir Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Daclatasvir Dihydrochloride USDMF includes data on Daclatasvir Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Daclatasvir Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Daclatasvir Dihydrochloride suppliers with USDMF on PharmaCompass.
A Daclatasvir Dihydrochloride written confirmation (Daclatasvir Dihydrochloride WC) is an official document issued by a regulatory agency to a Daclatasvir Dihydrochloride manufacturer, verifying that the manufacturing facility of a Daclatasvir Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Daclatasvir Dihydrochloride APIs or Daclatasvir Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Daclatasvir Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Daclatasvir Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Daclatasvir Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Daclatasvir Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Daclatasvir Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Daclatasvir Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Daclatasvir Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Daclatasvir Dihydrochloride suppliers with NDC on PharmaCompass.
Daclatasvir Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Daclatasvir Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Daclatasvir Dihydrochloride GMP manufacturer or Daclatasvir Dihydrochloride GMP API supplier for your needs.
A Daclatasvir Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Daclatasvir Dihydrochloride's compliance with Daclatasvir Dihydrochloride specifications and serves as a tool for batch-level quality control.
Daclatasvir Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Daclatasvir Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Daclatasvir Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Daclatasvir Dihydrochloride EP), Daclatasvir Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Daclatasvir Dihydrochloride USP).